StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $61.08MP/E –Yield –

Nuo Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

Nuo Therapeutics's R&D Expenses for the twelve months ending Dec 31, 2021 was $0. For fiscal 2021 it was $0. The highest annual figure on record is $4.04M in fiscal 2014.

Annual r&d expenses

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$181.19K-68.6%
FY2018Dec 31, 2018$576.19K-56.6%
FY2017Dec 31, 2017$1.33M-47.9%
FY2015Dec 31, 2015$2.55M-36.8%
FY2014Dec 31, 2014$4.04M+6.3%
FY2013Dec 31, 2013$3.80M+12.2%
FY2012Dec 31, 2012$3.39M+3350.3%
FY2011Dec 31, 2011$98.15K-76.4%
FY2010Dec 31, 2010$415.63K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0-100.0%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$2.70K-97.2%
Q2 FY2019Jun 30, 2019$84.14K-39.9%
Q1 FY2019Mar 31, 2019$94.35K-63.4%
Q4 FY2018Dec 31, 2018$82.60K-74.2%
Q3 FY2018Sep 30, 2018$95.49K-68.1%
Q2 FY2018Jun 30, 2018$140.07K-54.7%
Q1 FY2018Mar 31, 2018$258.04K-35.4%
Q4 FY2017Dec 31, 2017$319.95K–
Q3 FY2017Sep 30, 2017$299.48K–
Q2 FY2017Jun 30, 2017$309.49K–
Q1 FY2017Mar 31, 2017$399.41K–

More Nuo Therapeutics figures

See a number that looks wrong?